Regulation of brain function by exercise

Neurobiology of Disease

Volumn 13, Issue 1, 2003, Pages 1-14

  Sutoo, Den'etsu ^a   Akiyama, Kayo ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Alzheimer's disease; Calcium CaM dependent dopamine synthesis; Epilepsy; Exercise; Hypertension; Parkinson's disease; Senile dementia

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; CALCIUM; CALCIUM CHLORIDE; CALMODULIN INHIBITOR; DOPAMINE; DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR BLOCKING AGENT; EDETIC ACID; ETICLOPRIDE; FENCLONINE; HERBACEOUS AGENT; LEVODOPA; METIROSINE; METOCLOPRAMIDE; MONOAMINE OXIDASE INHIBITOR; N (6 AMINOHEXYL) 5 CHLORO 1 NAPHTHALENESULFONAMIDE; NORADRENALIN; PERGOLIDE; SULPIRIDE; TRIFLUOPERAZINE;

BLOOD PRESSURE; BLOOD PRESSURE REGULATION; BRAIN DISEASE; BRAIN FUNCTION; BRAIN REGION; CALCIUM BLOOD LEVEL; CALCIUM METABOLISM; CALCIUM TRANSPORT; CHINESE MEDICINE; CLINICAL FEATURE; CONVULSION; DOPAMINE BRAIN LEVEL; DOPAMINE METABOLISM; DYNAMIC EXERCISE; EPILEPSY; ESSENTIAL HYPERTENSION; HYPERTENSION; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MOUSE STRAIN; NEUROLOGIC DISEASE; NONHUMAN; NORADRENALIN BRAIN LEVEL; PARKINSON DISEASE; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SENILE DEMENTIA; SLEEP INDUCTION; TREATMENT OUTCOME;

EID: 0037654785     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-9961(03)00030-5     Document Type: Review

References (108)

1. Addison W.L.T. The use of calcium chloride in arterial hypertension. Can. Med. Assoc. J. 14:1924;1059-1061.
2. Addison W.L.T., Clark H.G. Calcium and potassium chlorides in the treatment of arterial hypertension. Can. Med. Assoc. J. 15:1925;913-915.
3. Adolfsson R., Gottfries C.G., Roos B.E., Winblad B. Changes in the brain catecholamines in patients with dementia of Alzheimer type. Br. J. Psychiatry. 135:1979;216-223.
4. Akiyama K., Sutoo D. Rectifying effect of exercise on hypertension in spontaneously hypertensive rats via a calcium-dependent dopamine synthesizing system in the brain. Brain Res. 823:1999;154-160.
5. Akiyama K., Yabe K., Sutoo D. Quantitative immunohistochemical distributions of tyrosine hydroxylase and calmodulin in the brains of spontaneously hypertensive rats. Kitasato Arch. Exp. Med. 65:1992;199-208.
6. Alexander R.S. Tonic and reflex functions of medullary sympathetic cardiovascular centers. J. Neurophysiol. 9:1946;205-217.
7. 3H]GBR-12935 in Alzheimer's disease. Eur. Neurol. 30:1990;181-185.
8. Allard P.O., Rinne J., Marcusson J.O. Dopamine uptake sites in Parkinson's disease and in dementia of the Alzheimer type. Brain Res. 637:1994;262-266.
9. Arai H., Kosaka K., Iizuka R. Changes of biogenic amines and their metabolites in postmortem brains from patients with Alzheimer-type dementia. J. Neurochem. 43:1984;388-393.
10. Arroll B., Beaglehole R. Does physical activity lower blood pressure a critical review of the clinical trials . J. Clin. Epidemiol. 45:1992;439-447.
11. Baatile J., Langbein W.E., Weaver F., Maloney C., Jost M.B. Effect of exercise on perceived quality of life of individuals with Parkinson's disease. J. Rehabil. Res. Dev. 37:2000;529-534.
12. Barkai A.I., Meltzer H.L. Regulation of calcium entry into the extracellular environment of the rat brain. J. Neurosci. 2:1982;1322-1328.
13. Beck N., Webster S.K. Effects of acute metabolic acidosis on parathyroid hormone action and calcium mobilization. Am. J. Physiol. 230:1976;127-131.
14. Bowdler J.M., Green A.R., Rawle F.C. Brain and serum calcium concentrations following electroconvulsive shock or bicuculline-induced convulsions in rats. Br. J. Pharmacol. 71:1980;321-325.
15. Boyer J.L., Kasch F.W. Exercise therapy in hypertensive men. JAMA. 211:1970;1668-1671.
16. Brahm H., Piehl-Aulin K., Ljunghall S. Bone metabolism during exercise and recovery the influence of plasma volume and physical fitness . Calcif. Tissue Int. 61:1997;192-198.
17. Broe G.A., Henderson A.S., Creasey H., McCusker E., Korten A.E., Jorm A.F., Longley W., Anthony J.C. A case-control study of Alzheimer's disease in Australia. Neurology. 40:1990;1698-1707.
18. Bustos G., Simon J., Roth R.H. Tyrosine hydroxylase regulation apparent kinetic alterations following incubation of brain slices in a sodium-free medium . J. Neurochem. 35:1980;47-57.
19. Cooper K.H., Pollock M.L., Martin R.P., White S.R., Linnerud A.C., Jackson A. Physical fitness levels vs. selected coronary risk factors a cross-sectional study . JAMA. 236:1976;166-169.
20. Cortés R., Probst A., Palacios J.M. Decreased densities of dopamine D1 receptors in the putamen and hippocampus in senile dementia of the Alzheimer type. Brain Res. 475:1988;164-167.
21. Cott J.M., Breese G.R., Cooper B.R., Barlow T.S., Prange A.J. Jr. Investigations into the mechanism of reduction of ethanol sleep by thyrotropin-releasing hormone (TRH). J. Pharmacol. Exp. Ther. 196:1976;594-604.
22. Cross A.J., Crow T.J., Ferrier I.N., Johnson J.A., Markakis D. Striatal dopamine receptors in Alzheimer-type dementia. Neurosci. Lett. 52:1984;1-6.
23. Cunningham J., Segre G.V., Slatopolsky E., Avioli L.V. Effect of heavy exercise on mineral metabolism and calcium regulating hormones in humans. Calcif. Tissue Int. 37:1985;598-601.
24. Dittmar C. Ein neuer Beweis fur die Reizbarkeit der centripetalen Endfasern des Ruckenmarks. Akad. Wiss. Leipzig. Math-Phys. Kl. (Berichte). 22:1870;18-45.
25. Edwards M.T., Diana J.N. Effect of exercise on pre- and postcapillary resistance in the spontaneously hypertensive rat. Am. J. Physiol. 234:1978;H439-H446.
26. 2+-dependent phosphorylation. Nature. 302:1983;830-832.
27. +-induced depolarization and/or forskolin in rat striatal slices. J. Neurochem. 45:1985;173-184.
28. Evenwel R., Struyker-Boudier H. Effect of physical training on the development of hypertension in the spontaneously hypertensive rat. Pflugers Arch. 381:1979;19-24.
29. Folkow B. Physiological aspects of primary hypertension. Physiol. Rev. 62:1982;347-504.
30. Folkow B., Johansson B., Oberg B. A hypothalamic structure with a marked inhibitory effect on tonic sympathetic activity. Acta Physiol. Scand. 47:1959;262-270.
31. Fujii T., Nonaka C., Ikeda H. Differential effects of picrotoxin- and pentylenetetrazol-induced convulsions on the secretion of luteinizing hormone and follicle-stimulating hormone in rats. Psychoneuroendocrinology. 9:1984;391-397.
32. Gottfries C.-G., Adolfsson R., Aquilonius S.-M., Carlsson A., Eckernäs S.-Å., Nordberg A., Oreland L., Svennerholm L., Wiberg Å., Winblad B. Biochemical changes in dementia disorders of Alzheimer type (AD/SDAT). Neurobiol. Aging. 4:1983;261-271.
33. Graziani L.J., Kaplan R.K., Escriva A., Katzman R. Calcium flux into CSF during ventricular and ventriculocisternal perfusion. Am. J. Physiol. 213:1967;629-636.
34. 2 receptors in the rat brain. Eur. J. Pharmacol. 111:1985;191-199.
35. Hansen L., Salmon D., Galasko D., Masliah E., Katzman R., DeTeresa R., Thal L., Pay M.M., Hofstetter R., Klauber M., Rice V., Butters N., Alford M. The Lewy body variant of Alzheimer's disease a clinical and pathologic entity . Neurology. 40:1990;1-8.
36. Hara M., Sasa M., Kawabata A., Serikawa T., Yamada T., Yamada J., Takaori S. Decreased dopamine and increased norepinephrine levels in the spontaneously epileptic rat, a double mutant rat. Epilepsia. 34:1993;433-440.
37. Hiramatsu M. Brain monoamine levels and El mouse convulsions. Folia Psychiatr. Neurol. Jpn. 35:1981;261-266.
38. Hurwitz A. The benefit of a home exercise regimen for ambulatory Parkinson's disease patients. J. Neurosci. Nurs. 21:1989;180-184.
39. Imaizumi K., Ito S., Kutsukake G., Takizawa T., Fujiwara K., Tsuchikawa T. Epilepsy-like anomaly of mice. Exp. Anim. 8:1959;6-10.
40. Itagaki C., Isobe T., Taoka M., Natsume T., Nomura N., Horigome T., Omata S., Ichinose H., Nagatsu T., Greene L.A., Ichimura T. Stimulus-coupled interaction of tyrosine hydroxylase with 14-3-3 proteins. Biochemistry. 38:1999;15673-15680.
41. Jadhav A.L., Willett R.N., Sapru H.N., Lokhandwala M.F. Involvement of central dopamine receptors in the hypotensive action of pergolide. Naunyn Schmiedebergs Arch. Pharmacol. 324:1983;281-286.
42. Kandel E.R., Schwartz J.H., Jessell T.M. Principles of Neural Science. 3rd ed: 1991;Elsevier, New York. pp. 654-655.
43. Kemppainen N., Marjamäki P., Röyttä M., Rinne J.O. Different pattern of reduction of striatal dopamine reuptake sites in Alzheimer's disease and ageing. J. Neural Transm. 108:2001;827-836.
44. Kemppainen N., Ruottinen H., Någren K., Rinne J.O. PET shows that striatal dopamine D1 and D2 receptors are differentially affected in AD. Neurology. 55:2000;205-209.
45. Kenney M.J., Seals D.R. Postexercise hypotension key features, mechanisms, and clinical significance . Hypertension. 22:1993;653-664.
46. Kondo K., Suzuki H., Handa M., Nagahama S., Saruta T. Effects of intracerebroventricular administration of dopamine and metoclopramide on blood pressure in rats. Arch. Int. Pharmacodyn. Ther. 250:1981;273-278.
47. Kuroda K., Tatara K., Shinsho H., Okamoto E., Cho R., Nishigaki C., Takatorige T., Nakanishi N., Aoki T. A study of attitudes toward illness and its effect on mortality in patients with Parkinson's disease [Japanese]. Nippon Koshu Eisei Zasshi. 37:1990;333-339.
48. Kuroda K., Tatara K., Takatorige T., Shinsho F. Effect of physical exercise on mortality in patients with Parkinson's disease. Acta Neurol. Scand. 86:1992;55-59.
49. Kusano S., Seto S., Akahoshi M., Kitamura S., Nagao S., Ozeki S., Yano K., Hashiba K. Depressor effect of intraventricular administration of calcium on spontaneously hypertensive rats. Brain Res. 618:1993;63-70.
50. Landolt H. Some clinical electroencephalographical correlations in epileptic psychoses (twilight states). Electroencephalogr. Clin. Neurophysiol. Abstr. 5:1953;121.
51. Langlais P.J., Thal L., Hansen L., Galasko D., Alford M., Masliah E. Neurotransmitters in basal ganglia and cortex of Alzheimer's disease with and without Lewy bodies. Neurology. 43:1993;1927-1934.
52. Laurin D., Verreault R., Lindsay J., MacPherson K., Rockwood K. Physical activity and risk of cognitive impairment and dementia in elderly persons. Arch. Neurol. 58:2001;498-504.
53. Ljunghall S., Joborn H., Lundin L., Rastad J., Wide L., Åkerström G. Regional and systemic effects of short-term intense muscular work on plasma concentration and content of total and ionized calcium. Eur. J. Clin. Invest. 15:1985;248-252.
54. Ljunghall S., Joborn H., Roxin L.-E., Rastad J., Wide L., Åkerström G. Prolonged low-intensity exercise raises the serum parathyroid hormone levels. Clin. Endocrinol. 25:1986;535-542.
55. Lökk J. The effects of mountain exercise in Parkinsonian persons - a preliminary study. Arch. Gerontol. Geriatr. 31:2000;19-25.
56. Matsukura T., Sutoo D., Akiyama K., Yabe K. The role of calcium and striatal dopamine in the blood pressure regulation. Proc. Dopamine Abstr. 94:1994;S25.
57. Miyai I., Fujimoto Y., Ueda Y., Yamamoto H., Nozaki S., Saito T., Kang J. Treadmill training with body weight support its effect on Parkinson's disease . Arch. Phys. Med. Rehabil. 81:2000;849-852.
58. Nazarali A.J., Reynolds G.P. Monoamine neurotransmitters and their metabolites in brain regions in Alzheimer's disease a postmortem study . Cell. Mol. Neurobiol. 12:1992;581-587.
59. Nielsen S.P., Christiansen T.F., Hartling O., Trap-Jensen J. Increase in serum ionized calcium during exercise. Clin. Sci. Mol. Med. 53:1977;579-586.
60. Palmer S.S., Mortimer J.A., Webster D.D., Bistevins R., Dickinson G.L. Exercise therapy for Parkinson's disease. Arch. Phys. Med. Rehabil. 67:1986;741-745.
61. Perry E., Court J., Goodchild R., Griffiths M., Jaros E., Johnson M., Lloyd S., Piggott M., Spurden D., Ballard C., McKeith I., Perry R. Clinical neurochemistry developments in dementia research based on brain bank material . J. Neural. Transm. 105:1998;915-933.
62. Perry E.K., Marshall E., Perry R.H., Irving D., Smith C.J., Blessed G., Fairbairn A.F. Cholinergic and dopaminergic activities in senile dementia of Lewy body type. Alzheimer Dis. Assoc. Disord. 4:1990;87-95.
63. Petersen D.R., Fish B.S., Collins A.C. Monoamine oxidase inhibitors influence on ethanol-induced sleep time and ethanol metabolism . Curr. Alcohol. 3:1978;153-172.
64. Piggott M.A., Marshall E.F., Thomas N., Lloyd S., Court J.A., Jaros E., Burn D., Johnson M., Perry R.H., McKeith I.G., Ballard C., Perry E.K. Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases rostrocaudal distribution . Brain. 122:1999;1449-1468.
65. 123I]-IBZM . Neurology. 47:1996;1065-1068.
66. Reuter I., Engelhardt M., Stecker K., Baas H. Therapeutic value of exercise training in Parkinson's disease. Med. Sci. Sports Exerc. 31:1999;1544-1549.
67. Richtand N., Schworer C., Kuczenski R., Soderling T.R. Phosphorylation of brain tyrosine hydroxylase by calcium, calmodulin-dependent protein kinase. Fed. Proc. Abstr. 44:1985;705.
68. 11C]β-CFT is reduced in Alzheimer's disease assessed by positron emission tomography. Neurology. 50:1998;152-156.
69. Rinne J.O., Säkö E., Paljärvi L., Mölsä P.K., Rinne U.K. Brain dopamine D-2 receptors in senile dementia. J. Neural. Transm. 65:1986;51-62.
70. Rolland Y., Rival L., Pillard F., Lafont C.H., Riviere D., Albarede J.-L., Vellas B. Feasibily of regular physical exercise for patients with moderate to severe Alzheimer disease. J. Nutr. Health Aging. 4:2000;109-113.
71. Rosenfeld G. Potentiation of the narcotic action and acute toxicity of alcohol by primary aromatic monoamines. Q. J. Stud. Alcohol. 21:1960;584-596.
72. Ruben J.A., Bennett A.F. Intense exercise, bone structure and blood calcium levels in vertebrates. Nature. 291:1981;411-413.
73. Salvesen H., Johansson A.G., Foxdal P., Wide L., Piehl-Aulin K., Ljunghall S. Intact serum parathyroid hormone levels increase during running exercise in well-trained men. Calcif. Tissue Int. 54:1994;256-261.
74. Schworer C.M., Soderling T.R. Substrate specificity of liver calmodulin-dependent glycogen synthase kinase. Biochem. Biophys. Res. Commun. 116:1983;412-416.
75. Shimamura K., Takatsuka N., Inaba R., Iwata H., Yoshida H. Environmental factors possibly associated with onset of senile dementia [Japanese]. Nippon Koshu Eisei Zasshi. 45:1998;203-212.
76. Shyu B.C., Thorén P. Circulatory events following spontaneous muscle exercise in normotensive and hypertensive rats. Acta Physiol. Scand. 128:1986;515-524.
77. Storga D., Vrecko K., Birkmayer J.G.D., Reibnegger G. Monoaminergic neurotransmitters, their precursors and metabolites in brains of Alzheimer patients. Neurosci. Lett. 203:1996;29-32.
78. Sunvisson H., Lökk J., Erickson K., Winblad B., Ekman S.-L. Changes in motor performance in persons with Parkinson's disease after exercise in a mountain area. J. Neurosci. Nurs. 29:1997;255-260.
79. Sutoo D. Disturbances of brain function by exogenous cadmium. Isaacson R.L., Jensen K.F. The Vulnerable Brain and Environmental Risks, Vol. 3. Toxins in Air and Water. 1994;281-300 Plenum Press, New York.
80. Sutoo D., Akiyama K. The role of sympathetic nervous function in the central calcium-dependent blood pressure regulation system. Jpn. J. Pharmacol. Abstr. 55:(Suppl. I):1991;339.
81. Sutoo D., Akiyama K. The mechanism by which exercise modifies brain function. Physiol. Behav. 60:1996;177-181.
82. Sutoo D., Akiyama K. Regulation of blood pressure with calcium-dependent dopamine synthesizing system in the brain and its related phenomena. Brain Res. Rev. 25:1997;1-26.
83. Sutoo D., Akiyama K. Effect of dopamine receptor antagonists on the calcium-dependent central function that reduces blood pressure in spontaneously hypertensive rats. Neurosci. Lett. 269:1999;133-136.
84. Sutoo D., Akiyama K., Geffard M. Central dopamine-synthesis regulation by the calcium-calmodulin-dependent system. Brain Res. Bull. 22:1989;565-569.
85. Sutoo D., Akiyama K., Iimura K. Effect of calmodulin antagonists on calcium and ethanol-induced sleeping time in mice. Pharmacol. Biochem. Behav. 23:1985;627-631.
86. Sutoo D., Akiyama K., Iimura K. The ability of divalent cations to enhance ethanol-induced sleeping time. Alcohol. 3:1986;69-72.
87. Sutoo D., Akiyama K., Maeda I. The development of a high sensitivity and high linearity fluorescence microphotometry system for distribution analysis of neurotransmitter in the brain [Japanese]. Folia Pharmacol. Jpn. 91:1988;173-180.
88. Sutoo D., Akiyama K., Matsukura T., Nakamoto R.K. Decrease of central dopamine level in the adult spontaneously hypertensive rats related to the calcium metabolism disorder. Brain Res. Bull. 30:1993;107-113.
89. Sutoo D., Akiyama K., Takita H. The relationship between metal ion levels and biogenic amine levels in epileptic mice. Brain Res. 418:1987;205-213.
90. Sutoo D., Akiyama K., Takita H. Effect of intraventricular administration of calcium on the lowering of brain dopamine level in epileptic mice. Epilepsy Res. 6:1990;199-204.
91. Sutoo D., Akiyama K., Takita H. The effect of convulsions on the rectification of central nervous system disorders in epileptic mice. Physiol. Behav. 52:1992;865-872.
92. Sutoo D., Akiyama K., Takita H. Abnormal behavior in epileptic El mice related to a calcium-dependent-catecholamine synthesis disorder of the central nervous system. Neurosciences. 18:(Suppl. 2):1992;55-62.
93. Sutoo D., Akiyama K., Yabe K. Quantitative mapping analyzer for determining the distribution of neurochemicals in the human brain. J. Neurosci. Methods. 85:1998;161-173.
94. Sutoo D., Akiyama K., Yabe K. Quantitative imaging of tyrosine hydroxylase and calmodulin in the human brain. J. Neurosci. Res. 63:2001;369-376.
95. Sutoo D., Akiyama K., Yabe K. Comparison analysis of distributions of tyrosine hydroxylase, calmodulin and calcium/calmodulin-dependent protein kinase II in a triple stained slice of rat brain. Brain Res. 933:2002;1-11.
96. Sutoo D., Akiyama K., Yabe K., Kohno K. Multiple analysis of tyrosine hydroxylase and calmodulin distributions in the forebrain of the rat using a microphotometry system. Brain Res. Bull. 26:1991;973-982.
97. Sutoo D., Akiyama K., Yabe K., Kohno K. Quantitative analysis of immunohistochemical distributions of cholinergic and catecholaminergic systems in the human brain. Neuroscience. 58:1994;227-234.
98. Sutoo D., Matsukura T., Akiyama K. Effect of intraventricular administration of calcium and calmodulin antagonist on the blood pressure in the rat. Neurosci. Lett. 82:1987;297-302.
99. Sutoo D., Matsukura T., Akiyama K. The mechanism by which calcium reduces blood pressure. Eur. J. Pharmacol. 155:1988;189-192.
100. Sutoo D., Sano K. Modulating effects of biogenic amines on calcium and ethanol-induced sleeping time. Alcohol. 1:1984;141-144.
101. Suzuki J. Paroxysmal discharges in the electroencephalogram of the El mouse. Experientia. 32:1976;336-337.
102. Tai C.-Y., Smith Q.R., Rapoport S.I. Calcium influxes into brain and cerebrospinal fluid are linearly related to plasma ionized calcium concentration. Brain Res. 385:1986;227-236.
103. Tellenbach H. Epilepsy as an ictal disease and as a psychosis. Alternative psychoses of paranoid nature as a result of "enforced normalization" (Landolt) of the electroencephalogram of epileptics. Nervenarzt. 36:1965;190-202.
104. Vora N.M., Kukreja S.C., York P.A.J., Bowser E.N., Hargis G.K., Williams G.A. Effect of exercise on serum calcium and parathyroid hormone. J. Clin. Endocrinol. Metab. 57:1983;1067-1069.
105. Vulliet P.R., Woodgett J.R., Cohen P. Phosphorylation of tyrosine hydroxylase by calmodulin-dependent multiprotein kinase. J. Biol. Chem. 259:1984;13680-13683.
106. Wachman A., Bernstein D.S. Parathyroid hormone in metabolic acidosis its role in pH homeostasis . Clin. Orthop. Related Res. 69:1970;252-263.
107. Wallin A., Gottfries C.-G. Biochemical substrates in normal aging and Alzheimer's disease. Pharmacopsychiatry. 23:(Suppl.):1990;37-43.
108. 2+-, calmodulin-dependent protein kinase, followed by activation by activator protein. Biochem. Biophys. Res. Commun. 100:1981;807-813.